Aethlon Medical, Inc. (AEMD) has priced a public offering of 5,000,000 shares of common stock or pre-funded warrants at $0.90 per unit. The accompanying warrants are exercisable immediately at $0.90 and expire in five years. The offering is expected to close on or about September 5, 2025, with gross proceeds totaling approximately $4.5 million. Maxim Group LLC is the exclusive placement agent for the offering. Aethlon plans to use the net proceeds for general corporate purposes, including clinical trials and R&D. The offering is being made under a Form S-1 registration statement declared effective by the SEC on September 4, 2024. On Thursday, AEMD closed at $0.7341, down 45.62%, and traded after hours to close at $0.7799, up 6.24% on the NasdaqCM.

Read more at Nasdaq: Aethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants